Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure

Xiuli Mu, Shinji Hasegawa, Jun Yoshioka, Atsushi Maruyama, Kaoru Maruyama, Asit K. Paul, Hitoshi Yamaguchi, Takakazu Morozumi, Katsuji Hashimoto, Hideo Kusuoka, Tsunehiko Nishimura

Research output: Contribution to journalArticle

Abstract

This study investigated the clinical value of I-123 MIBG pulmonary accumulation and washout in patients with chronic heart failure (CHF). Nineteen patients with CHF and 15 normal volunteers (NL) were included. The uptake ratio of heart to mediastinum (H/M), that of lung fields to mediastinum (L/M), and washout rate (WR) of the heart and lung fields were calculated in anterior planar images and compared with results of echocardiography and cardiac catheterization. In the CHF group, the lung uptake in delayed images increased and lung WR was decreased, suggesting pulmonary endothelial lesions. Furthermore, there was a negative correlation between right and left lung WR and pulmonary arterial diastolic pressure (PA(D)) and pulmonary arterial systolic pressure (PA(s)) in the CHF group. Since the WR of MIBG reflected PA, it may be used as an index of severity of cardiac dysfunction.

Original languageEnglish (US)
Pages (from-to)411-416
Number of pages6
JournalAnnals of Nuclear Medicine
Volume15
Issue number5
StatePublished - 2001
Externally publishedYes

    Fingerprint

Keywords

  • Chronic heart failure
  • Iodine-123 MIBG
  • Lung uptake

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Mu, X., Hasegawa, S., Yoshioka, J., Maruyama, A., Maruyama, K., Paul, A. K., Yamaguchi, H., Morozumi, T., Hashimoto, K., Kusuoka, H., & Nishimura, T. (2001). Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure. Annals of Nuclear Medicine, 15(5), 411-416.